🇺🇸 FDA
Patent

US 9370521

Targeting GLI proteins in human cancer by small molecules

granted A61KA61K31/415A61K31/4155

Quick answer

US patent 9370521 (Targeting GLI proteins in human cancer by small molecules) held by The Regents of the University of California expires Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 21 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 16 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K31/415, A61K31/4155, A61K31/4439, A61K31/517